103 related articles for article (PubMed ID: 2137945)
21. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
Kaplan KL; Drillings M; Lesznik G
J Clin Invest; 1981 May; 67(5):1561-8. PubMed ID: 6453136
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
23. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
24. Protein C in acute stroke.
D'Angelo A; Landi G; Vigano'D'Angelo S; Nobile Orazio E; Boccardi E; Candelise L; Mannucci PM
Stroke; 1988 May; 19(5):579-83. PubMed ID: 3363590
[TBL] [Abstract][Full Text] [Related]
25. Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations.
Neri Serneri GG; Gensini GF; Abbate R; Mugnaini C; Favilla S; Brunelli C; Chierchia S; Parodi O
Am Heart J; 1981 Feb; 101(2):185-94. PubMed ID: 6451162
[TBL] [Abstract][Full Text] [Related]
26. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
27. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
28. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
[TBL] [Abstract][Full Text] [Related]
29. Single lacunar brain infarction with transient signs versus those with long-lasting signs.
Oishi M; Mochizuki Y; Shikata E
Int Angiol; 1999 Sep; 18(3):206-9. PubMed ID: 10688419
[TBL] [Abstract][Full Text] [Related]
30. Molecular markers of hemostasis activation in nephrotic syndrome.
Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
[TBL] [Abstract][Full Text] [Related]
31. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
32. Activation of coagulation and fibrinolytic systems following stroke.
Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
[TBL] [Abstract][Full Text] [Related]
33. Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension.
Douglas JT; Shah M; Lowe GD; Belch JJ; Forbes CD; Prentice CR
Thromb Haemost; 1982 Feb; 47(1):54-5. PubMed ID: 6176042
[TBL] [Abstract][Full Text] [Related]
34. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
35. Enhanced in vivo platelet activation in subtypes of ischemic stroke.
Shah AB; Beamer N; Coull BM
Stroke; 1985; 16(4):643-7. PubMed ID: 3161220
[TBL] [Abstract][Full Text] [Related]
36. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
37. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
38. Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions.
Tsuda Y; Satoh K; Kitadai M; Takahashi T
J Neurol Sci; 1997 Mar; 147(1):49-54. PubMed ID: 9094060
[TBL] [Abstract][Full Text] [Related]
39. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
40. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
